Clinical Trial Update: Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating rituximab for ocular cicatricial pemphigoid has completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Cicatricial Pemphigoid

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Ocular Cicatricial Pemphigoid | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2011-04-21